Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.3%

1 terminated/withdrawn out of 30 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
14(87.5%)
Phase 3
1(6.3%)
Phase 4
1(6.3%)
16Total
N/A(14)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT05656976Not ApplicableActive Not Recruiting

Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women

Role: collaborator

NCT07411001Not ApplicableActive Not Recruiting

Hypiend - Multicomponent Behavioral Intervention in Pre-puberal Children (Hypiend-PPC)

Role: lead

NCT04788849Completed

Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples

Role: collaborator

NCT05996783Not ApplicableActive Not Recruiting

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

Role: collaborator

NCT05243888Not ApplicableActive Not Recruiting

Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening

Role: collaborator

NCT06714149Not ApplicableRecruiting

Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium

Role: collaborator

NCT06007001Not ApplicableRecruiting

Telerehabilitation and Tele-psychological Support in Cancer Patients eCAN JA

Role: lead

NCT04779424Completed

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)

Role: collaborator

NCT04903561Not ApplicableUnknown

Increase in Response by Offering Self-sampling Devices in Belgian GP Practices to Non-screened Women

Role: lead

NCT04738695Completed

SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19)

Role: lead

NCT05827601Unknown

Zoonotic Influenza Surveillance in Belgium

Role: collaborator

NCT05620953Completed

Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)

Role: lead

NCT05996796Not ApplicableCompleted

Dry Run of the ScreenUrSelf Trial

Role: collaborator

NCT04527614Not ApplicableCompleted

Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection

Role: lead

NCT04852861Phase 4Completed

COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine

Role: lead

NCT04469634Not ApplicableCompleted

Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?

Role: collaborator

NCT05193669Unknown

Clinical Validation of Molecular Triage in HR-HPV Positive Women

Role: collaborator

NCT04312737Completed

Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus

Role: collaborator

NCT05618548Unknown

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium

Role: collaborator

NCT04447521Unknown

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium

Role: lead